BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19702654)

  • 1. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors.
    Melve GK; Myrmel H; Eide GE; Hervig T
    Transfusion; 2009 Nov; 49(11):2359-65. PubMed ID: 19702654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity.
    Hitziger T; Schmidt M; Schottstedt V; Hennig H; Schumann A; Ross S; Lu M; Seifried E; Roggendorf M
    Transfusion; 2009 Jul; 49(7):1306-13. PubMed ID: 19309471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
    Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S
    Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-generation RIBA hepatitis C strip immunoblot assays.
    Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
    Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
    Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
    Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial experiences with HCV detection and confirmation tests of the 3rd generation].
    Knödler B; Kühnl P
    Beitr Infusionsther; 1993; 31():10-5. PubMed ID: 7693234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
    Myrmel H; Navaratnam V; Asjø B
    J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
    Dubois F; Barin F; Goudeau A
    Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of screening and complementary tests for anti-HCV antibodies].
    Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
    Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.